Pharmacogenomics (PGx) is fascinating since it studies drug response and genetics. This promising field may transform healthcare.
Over 16 hours of fascinating Pharmacogenomics in Clinical Practice content. View case studies and 50+ films anytime. The completion certificate and CME credit are offered.
Know It at Pharmacogenomics in Clinical Practice:
Post-activity participant skills:
- Pharmacogenomics basics.
- Consider clinical pharmacogenomics.
- Pharmacogenomics data can guide medication management.
- Examine patient care pharmacogenomics issues.
- No Mayo Clinic course guarantees skill in any care or procedure.
Program of Pharmacogenomics in Clinical Practice:
Integrating Pharmacogenomics into Clinical Practice
Pharmacogenomics (PGx) Principles And Concepts
- Pharmacogenomics 101: An Introduction to Foundational Concepts
Christopher T. Grilli, Pharm.D., R.Ph., M.B.A. - Variability and Pharmacokinetic Principles
Wayne T. Nicholson, M.D., Pharm.D. - Sex, Drugs, and Genetic Variation
Ann M. Moyer, M.D., Ph.D. - Pharmacogenomics’ Emerging Role
Richard Weinshilboum, M.D. - Pharmacogenomics: Discovery and Translation
Liewei Wang, M.D., Ph.D. - Untangling the Polypharmacy Burden with Pharmacogenomics Testing
Eric T. Matey, Pharm.D., R.Ph.
Pharmacogenomics (PGx) Rules And Regulations
- Legal Implications of Pharmacogenomics Testing
Sharon C. Zehe, J.D. - PGx from a Patient Perspective: GINA & Other Important Questions
Teresa M. Kruisselbrink, M.S., CGC, LCGC
Pharmacogenomics (PGx) Clinical Laboratory Testing
- Clinical Laboratory Testing in PGx: “the Lab” 101
Ann M. Moyer, M.D., Ph.D. - Clinical Laboratory Testing in PGx: Targeting Genotyping Technology
Ann M. Moyer, M.D., Ph.D. - Clinical Laboratory Testing in PGx: “Sequencing”
Ann M. Moyer, M.D., Ph.D. - Clinical Laboratory testing in PGx: “Reporting”
Ann M. Moyer, M.D., Ph.D.
Pharmacogenomics In Practice: General Principles
- Pharmacogenomics Testing: Role in Clinical Medicine
Denise M. Dupras, M.D., Ph.D. - 10 Considerations for the Clinician Applying Pharmacogenomics to Practice
Wayne T. Nicholson, M.D., Pharm.D. - Polypharmacy and PGx: Multi-Drug, Herbal/Dietary Supplement Case Study
Michael J. Schuh, Pharm.D., R.Ph. - Utilizing National Pharmacogenomics Guidelines and Other Resources
Jessica A. Wright, Pharm.D., R.Ph. - Case Review: From My Practice to Yours
Sheena K. Crosby, Pharm.D., R.Ph.
Pharmacogenomics In Practice: Panel Discussions
- Pharmacogenomics from the Patient Perspective
Darryl S. Chutka, M.D. (Moderator), Matthew J. Ferber, Ph.D., Karen M. Meagher, Ph.D. & Sharon C. Zehe, J.D. - Pharmacogenomics from the Clinician Perspective
Matthew E. Bernard, M.D., Jennifer A. Bold APRN, C.N.P., D.N.P., Darryl S. Chutka, M.D. (Moderator) & Paul Y. Takahashi, M.D. - Pharmacogenomics from the Pharmacy Perspective
Christopher Grilli, Pharm.D., R.Ph.,M.B.A. (Moderator), Ashley D. Ebenhoh, Pharm.D., R.Ph., & Razan M. El Melik, Pharm.D., R.Ph. - Education for the Multidisciplinary Team
Jyothsna (Jo) Giri, M.D., M.B.A., Christopher M. Kohler, M.A.N., R.N., N.E.-B.C., Tammy M. McAllister, M.A. (Moderator), & Lance J. Oyen, Pharm.D., R.Ph.
Pharmacogenomics In Practice: Analgesic/Anesthesia
- Pharmacogenomics of Analgesics
Wayne (Nick) T. Nicholson, M.D., Pharm.D. - Pharmacogenomics: Anesthesia
Timothy B. Curry, M.D., Ph.D.
Pharmacogenomics In Practice: Psychiatry
- Pharmacogenomics of Antidepressants
Adrijana Kekic, Pharm.D., R.Ph. - Case Review: Antidepressants, SSRIs (Sertraline) and SNRIs
Adrijana Kekic, Pharm.D., R.Ph. - Psychiatric Pharmacogenomics: Panel Discussion
Darryl S. Chutka, M.D. (Moderator), Eric T. Matey, Pharm.D., R.Ph., Denise M. Dupras, M.D., Ph.D., Richard Weinshilboum, M.D.
Pharmacogenomics In Practice: Cardiology/GI
- Pharmacogenomics in Cardiovascular Disease
Naveen L. Pereira, M.D. - Warfarin & Statin Pharmacogenomics Cases
Jan A. Anderson, Pharm.D., R.Ph. - PGx use in Patients with Gastroesophageal Reflux Disease
Imad Absah, M.D.
Pharmacogenomics In Practice: Oncology/Hematology
- Pharmacogenomics in Oncology
Eric J. Yancey, Pharm.D., R.Ph. - Why is CYP2D6 Genotyping Ready for Primetime: Association of CYP2D6 Genotype and Breast Cancer Outcome from Large Trials
Matthew P. Goetz, M.D. - Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Implications for 5-Fluorouracil (Capecitabine) Treatment
Robert B. Diasio, M.D. - Belinostat and UGT1A Polymorphism
N. Nora Bennani, M.D. - Case: Oncology
Caren L. Hughes, Pharm.D., R.Ph. - Case Study: Thiopurines/TPMT and NUDT15 in Clinical Practice
Edward V. Loftus, Jr. M.D.
Pharmacogenomics In Practice: Transplant, Infectious Disease, Immunology, Urology
- Pharmacogenomics for Transplant Patients: Immunosuppression and Beyond
Mira T. Keddis, M.D. - Pharmacogenomics: Challenges with Hematopoietic Stem Cell and Liver Transplantation
John Logan Black, M.D. - Voriconazole Case
Christopher J. Arendt, Pharm.D., R.Ph. - Using Pharmacogenomics to Predict Drug Hypersensitivity
John D. Zeuli, Pharm.D., R.Ph. - HLA and Hypersensitivity
Jyothsna (Jo) Giri, M.D., M.B.A. - Gout Management: Role of Pharmacogenomics
Denise M. Dupras, M.D., Ph.D.
Pharmacogenomics Implementation
- Significant Pharmacogenomics Cases
Heather H. Randles, Pharm.D., R.Ph. - Developing an Individualized Medication Plan
Eric T. Matey, Pharm.D., R.Ph.
See Also: Mayo Clinic Interventional Cardiology Review 2021 (45 Videos+102 PDF)
Reviews
There are no reviews yet.